UPDATE : Thursday, December 13, 2018
상단여백
SillaJen reveals clinical results on Pexa-Vec in UK
SillaJen said it unveiled clinical results of REN022, a phase-2 study on Pe...
by So Jae-hyeon  |  2018-04-13 16:38
라인
Hanmi gives up on lung cancer drug Olita
Hanmi Pharmaceutical is expected to discontinue developing lung cancer trea...
by Lee Hye-seon  |  2018-04-13 11:00
라인
LG Chem works on 3-in-1 combo for hypertension
LG Chem said it has won approval from the Ministry of Food and Drug Safety ...
by Lee Hye-seon  |  2018-04-12 16:32
라인
Obesity drug Saxenda’s sheds ‘1-year effect’ stigma
The government has changed its approval for the efficacy and safety of Saxe...
by Nam Doo-hyun  |  2018-04-11 14:11
라인
YD Life Science preps diabetes complication therapy for global launch
YD Life Science said it got the U.S. Food and Drug Administration’s go-ahea...
by Marian Chu  |  2018-04-10 17:36
라인
JW Pharm discovers novel H4R antagonist for atopic dermatitis
JW Pharmaceuticals Tuesday said it discovered a novel orally available H4R ...
by Marian Chu  |  2018-04-10 17:36
라인
Janssen Korea gets reimbursement for leukemia drug
Janssen Korea said Tuesday that it got the Ministry of Health and Welfare’s...
by Marian Chu  |  2018-04-10 16:14
라인
LG Chem, Merck to co-market hypertension drug
LG Chem and Merck Biopharma Korea said Monday the two firms agreed to sell ...
by So Jae-hyeon  |  2018-04-10 15:15
라인
Il-yang’s ‘Supect’ loses 2nd indication for leukemia
The government said Tuesday Il-yang Pharmaceutical’s Supect (ingredient: ra...
by Lee Hye-seon  |  2018-04-10 15:14
라인
Tamiflu crushed generic copies in flu season
Despite the massive release of generic copies with the expiration of Tamifl...
by So Jae-hyeon  |  2018-04-09 15:40
라인
Biosimilars take on original at breast cancer conference
Industry officials said they were able to witness the advent of biosimilar ...
by So Jae-hyeon  |  2018-04-09 15:05
라인
Boehringer Ingelheim Korea CEO was forced to resign?
Rumors are circulating in the pharmaceutical industry that Park Ki-hwan, CE...
by Nam Doo-hyun  |  2018-04-06 16:10
라인
GC Pharma starts testing anti-EGFR monoclonal antibody
GC Pharma said Thursday that it has launched phase 1b/2a clinical trials fo...
by Lee Han-soo  |  2018-04-05 15:44
라인
Janssen, Hanmi start phase-2 study on obesity, diabetes drug
Janssen and Hanmi Pharmaceutical will start a global phase-2 clinical trial...
by So Jae-hyeon  |  2018-04-05 15:06
라인
Korean biosimilars rarely prescribed in US
Korean biosimilar products are still struggling to penetrate the U.S. marke...
by So Jae-hyeon  |  2018-04-05 15:05
라인
HanAll wins patent for monoclonal antibody in Taiwan
HanAll Biopharma, a subsidiary of Daewoong Pharmaceuticals, said Tuesday th...
by Lee Han-soo  |  2018-04-04 16:07
라인
Will SGLT-2 combos with DPP-4 win insurance coverage?
Suppliers of antidiabetic medicines are paying attention to whether SGLT-2 ...
by So Jae-hyeon  |  2018-04-04 15:12
라인
Outpatient drug prescriptions plunged in February
The outpatient drug prescriptions market saw a drastic contraction in Febru...
by So Jae-hyeon  |  2018-04-03 16:59
라인
Sanofi Genzyme Korea gets go-ahead to market Dupixent
Sanofi Genzyme Korea, the specialty care division of the French pharmaceuti...
by Marian Chu  |  2018-04-03 15:23
라인
Ildong wins patent for retinal diseases biobetter treatment
Ildong Pharmaceutical said Monday that it has acquired a patent regarding t...
by Lee Han-soo  |  2018-04-03 14:35
여백
여백
여백
Back to Top